We believe that our present findings of chemopreventive and therapeutic efficacy of an epigenetic dietary agent pterostilbene as a novel MTA1-targeted strategy, may have potential clinical applications in prostate cancer management. The gene discussed is MTA1; the disease is prostate cancer.